Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Straub

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|February 20, 2010
Entering the era of non-basic p1 site groups: discovery of Xarelto (Rivaroxaban)Alexander Straub, Susanne Roehrig, Alexander Hillisch
Angewandte Chemie (International Ed. in English)|May 4, 2011
Oral, direct thrombin and factor Xa inhibitors: the replacement for warfarin, leeches, and pig intestines?Alexander Straub, Susanne Roehrig, Alexander Hillisch
Nature Reviews. Drug Discovery|December 18, 2010
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitorElisabeth Perzborn, Susanne Roehrig, Alexander Straub, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2010
Rivaroxaban: a new oral factor Xa inhibitorElisabeth Perzborn, Susanne Roehrig, Alexander Straub, et al.
IEEE Transactions on Visualization and Computer Graphics|October 25, 2023
Visual Analysis of Displacement Processes in Porous Media using Spatio-Temporal Flow GraphsAlexander Straub, Nikolaos Karadimitriou, Guido Reina, et al.
Journal of Medicinal Chemistry|September 16, 2005
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitorSusanne Roehrig, Alexander Straub, Jens Pohlmann, et al.
British Journal of Pharmacology|January 30, 2002
Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studiesJohannes-Peter Stasch, Cristina Alonso-Alija, Heiner Apeler, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulatorsNils Griebenow, Hartmut Schirok, Joachim Mittendorf, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
Metabolites of orally active NO-independent pyrazolopyridine stimulators of soluble guanylate cyclaseAlexander Straub, Jordi Benet-Buckholz, Rita Fröde, et al.
Angewandte Chemie (International Ed. in English)|August 22, 2013
The chemistry and biology of soluble guanylate cyclase stimulators and activatorsMarkus Follmann, Nils Griebenow, Michael G Hahn, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|February 20, 2010
Entering the era of non-basic p1 site groups: discovery of Xarelto (Rivaroxaban)Alexander Straub, Susanne Roehrig, Alexander Hillisch
Angewandte Chemie (International Ed. in English)|May 4, 2011
Oral, direct thrombin and factor Xa inhibitors: the replacement for warfarin, leeches, and pig intestines?Alexander Straub, Susanne Roehrig, Alexander Hillisch
Nature Reviews. Drug Discovery|December 18, 2010
The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitorElisabeth Perzborn, Susanne Roehrig, Alexander Straub, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2010
Rivaroxaban: a new oral factor Xa inhibitorElisabeth Perzborn, Susanne Roehrig, Alexander Straub, et al.
IEEE Transactions on Visualization and Computer Graphics|October 25, 2023
Visual Analysis of Displacement Processes in Porous Media using Spatio-Temporal Flow GraphsAlexander Straub, Nikolaos Karadimitriou, Guido Reina, et al.
Journal of Medicinal Chemistry|September 16, 2005
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitorSusanne Roehrig, Alexander Straub, Jens Pohlmann, et al.
British Journal of Pharmacology|January 30, 2002
Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studiesJohannes-Peter Stasch, Cristina Alonso-Alija, Heiner Apeler, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2013
Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulatorsNils Griebenow, Hartmut Schirok, Joachim Mittendorf, et al.
Bioorganic & Medicinal Chemistry|April 9, 2002
Metabolites of orally active NO-independent pyrazolopyridine stimulators of soluble guanylate cyclaseAlexander Straub, Jordi Benet-Buckholz, Rita Fröde, et al.
Angewandte Chemie (International Ed. in English)|August 22, 2013
The chemistry and biology of soluble guanylate cyclase stimulators and activatorsMarkus Follmann, Nils Griebenow, Michael G Hahn, et al.
Pageof 2